Synnovis brings ctDNA into NHS

- Synnovis partnered with SOPHiA GENETICS to provide routine blood‑based ctDNA testing for NHS lung and breast cancer patients as part of care pathways. (stocktitan.net) - The service reportedly supports about 400 patients per month and claims it can speed targeted‑therapy decisions by up to two weeks. (stocktitan.net) - Operational roll‑out of ctDNA at scale underscores the growing need for specimen triage and logistics expertise in hospital labs handling molecular requests. (stocktitan.net)